The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Topic: atrial fibrillation - Primary Care

Wednesday, 21 February 2018
Atrial fibrillation (AF) is the commonest sustained cardiac dysrhythmia, but is asymptomatic in about one quarter of patients. Case finding with subsequent assessment of the risk of stroke and bleeding are essential to ensure that the right patients receive appropriate intervention with oral anticoagulation.
Category: Editorial
Friday, 02 August 2019
Atrial fibrillation (AF) management has been transformed within the last decade by revised clinical guidance and availability of new drugs. Aspirin monotherapy, once accounting for almost half of all antithrombotic prescriptions for AF, is now an obsolete therapy. Anticoagulation is the treatment of choice for AF and direct oral anticoagulants (DOACs) have overtaken warfarin as the drug of first choice for new starters. However, management of one in four people with AF remains suboptimal, and this article reviews the major issues around antithrombotic and other treatments for AF.
Category: Editorial
Friday, 08 September 2017
This case study describes the diagnosis and management of AF in a 70-year old obese male who was referred for cardiac assessment after developing shortness of breath, which had worsened progressively over three months. It highlights the role of thromboembolic risk reduction which is the cornerstone of AF management and which can only be achieved with proper anticoagulation.
Category: Case Study
Tuesday, 20 March 2018
In 2015 West Hampshire CCG (WHCCG) recognised that there was a significant burden of undiagnosed atrial fibrillation (AF), which was resulting in an excess of preventable strokes. This could be improved by the prescription of anticoagulation in those at increased risk. 
Category: Editorial
Wednesday, 12 December 2018
Depressed people have an increased risk of atrial fibrillation, according to a study published in the European Journal of Preventive Cardiology. Filling a prescription for antidepressants, which was used in this study as an indicator of depression, was associated with a three-fold greater risk of atrial fibrillation. However, medication was not responsible for the high frequency of atrial fibrillation in depressed people.
Friday, 02 August 2019
Since 2014 the 15 Academic Health Science Networks (AHSNs) across England have been working on a collaborative atrial fibrillation (AF) programme focused on reducing AF-related stroke. The national programme has three elements: Detect: finding more people with AF to allow early intervention to prevent stroke; Protect: treating more at-risk patients with anticoagulants to reduce the rate of AF-related stroke; and Perfect: improving the quality of anticoagulation to ensure maximal patient outcomes.
Category: Editorial
Sunday, 12 March 2017
Atrial fibrillation patients with insulin-requiring diabetes are at greater risk of suffering a stroke or systemic embolism than those with non-insulin requiring diabetes, or no diabetes at all. While diabetes is a known risk factor for thromboembolic events, this finding sheds new light on the role of insulin in the clinical setting.
Monday, 17 July 2017
Arrhythmia Alliance, in collaboration with Happitech and Bug Labs, have launched the Heart for Heart e-health initiative where people can contribute their heart rhythm data using the free Heart for Heart iPhone app.
Category: Have You Heard
Monday, 19 December 2016
The UK charity Heart Valve Voice has developed the first practical guidance in heart valve disease for primary care. The disease is under-diagnosed and yet is increasing in prevalence as the population ages, so there is a need for primary care to plan an appropriate response.
Category: Editorial
Friday, 18 May 2018
An educational workshop at the 2017 Issues & Answers conference highlighted heart valve disease and the important role of primary care in its effective management. Across the UK approximately 1.5 million people >65 years are currently affected by the disease numbers predicted to more than double to 3.3 million by 2056.
Category: Editorial
Page 1 of 3

Article search and filter